Literature DB >> 20482942

Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory.

Flurin Cathomas1, Christian Vogler, Jessica C Euler-Sigmund, Dominique J-F de Quervain, Andreas Papassotiropoulos.   

Abstract

Brain-derived neurotrophic factor (BDNF) plays an important role in hippocampal synaptic plasticity and long-term potentiation. A valine (Val) to methionine (Met) substitution in the BDNF gene (Val66Met) has been associated with episodic memory performance. This study aimed at fine-mapping the genomic region harbouring BDNF and the adjacent gene, BDNFOS, in order to identify other possible memory-related gene variants. Healthy young Swiss adults (n=333) underwent a verbal memory free-recall task which used words with both neutral and emotional content. Genetic variability of the BDNF and BDNFOS region was covered by analysing 55 single nucleotide polymorphisms (SNPs). Among all examined SNPs, the non-synonymous Val66Met SNP rs6265 showed the highest significant level of association with memory performance for words with emotional content. Recall performance for neutral words was unrelated to the analysed SNPs. Our results support a role for the Val66Met BDNF polymorphism in episodic memory and suggest a modulatory influence of emotional valence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482942     DOI: 10.1017/S1461145710000519

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  16 in total

1.  The impact of brain-derived neurotrophic factor Val66Met polymorphism on cognition and functional brain networks in patients with intractable partial epilepsy.

Authors:  Meneka K Sidhu; Pamela J Thompson; Britta Wandschneider; Alexandra Foulkes; Jane de Tisi; Jason Stretton; Marina Perona; Maria Thom; Silvia B Bonelli; Jane Burdett; Elaine Williams; John S Duncan; Mar Matarin
Journal:  CNS Neurosci Ther       Date:  2018-06-27       Impact factor: 5.243

Review 2.  Potential therapeutic uses of BDNF in neurological and psychiatric disorders.

Authors:  Alan H Nagahara; Mark H Tuszynski
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

3.  The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury.

Authors:  Frank Krueger; Matteo Pardini; Edward D Huey; Vanessa Raymont; Jeffrey Solomon; Robert H Lipsky; Colin A Hodgkinson; David Goldman; Jordan Grafman
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

Review 4.  Brain-derived neurotrophic factor: its impact upon neuroplasticity and neuroplasticity inducing transcranial brain stimulation protocols.

Authors:  L Chaieb; A Antal; G G Ambrus; W Paulus
Journal:  Neurogenetics       Date:  2014-02-25       Impact factor: 2.660

5.  BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association.

Authors:  S D Mandelman; E L Grigorenko
Journal:  Genes Brain Behav       Date:  2011-12-05       Impact factor: 3.449

6.  GDNF and BDNF gene interplay in chronic tinnitus.

Authors:  Sand Pg; Langguth B; Schecklmann M; Kleinjung T
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

7.  BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons.

Authors:  Sandra Dieni; Tomoya Matsumoto; Martijn Dekkers; Stefanie Rauskolb; Mihai S Ionescu; Ruben Deogracias; Eckart D Gundelfinger; Masami Kojima; Sigrun Nestel; Michael Frotscher; Yves-Alain Barde
Journal:  J Cell Biol       Date:  2012-03-12       Impact factor: 10.539

8.  BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals.

Authors:  M Millan Sanchez; D Das; J L Taylor; A Noda; J A Yesavage; A Salehi
Journal:  Transl Psychiatry       Date:  2011-10-25       Impact factor: 6.222

9.  Effects of the BDNF Val66Met polymorphism and met allele load on declarative memory related neural networks.

Authors:  Chris M Dodds; Richard N Henson; John Suckling; Kamilla W Miskowiak; Cinly Ooi; Roger Tait; Fruzsina Soltesz; Phil Lawrence; Graham Bentley; Kay Maltby; Andrew Skeggs; Sam R Miller; Simon McHugh; Edward T Bullmore; Pradeep J Nathan
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.

Authors:  Roger A Dixon; Correne A DeCarlo; Stuart W S MacDonald; David Vergote; Jack Jhamandas; David Westaway
Journal:  Front Aging Neurosci       Date:  2014-09-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.